Found 9 matching trials
Lamazym Aftercare Study
PHASE3The overall objective of this trial is to provide aftercare treatment with ...
Location
Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9
A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis
PHASE3The overall objective of this trial is to evaluate the efficacy and safety ...
Location
Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9
Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis
PHASE2The main objectives of the study are to evaluate safety and efficacy of rep...
Location
Multiple Locations
Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
PHASE2This is a single-center, open-label, multiple-dose study of the efficacy an...
Location
Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9
Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients
PHASE3The overall objective of this trial is to provide aftercare treatment with ...
Location
Hôpital Femme Mére Enfant - CHU de Lyon
Evaluation of Long-term Efficacy of Treatment With Lamazym
PHASE3The overall objective is to evaluate the long-term efficacy of Lamazym i.v....
Location
Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9
Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis
PHASE2The overall objective is to evaluate the long-term efficacy, safety and tol...
Location
Kinderneurologie Metabole Ziekten, UZ Brussel, Laarbeeklaan 101
Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
PHASE1This is a single-center, open-label, dose escalation study of patients with...
Location
Multiple Locations
Expanded Access to Velmanase Alfa
N/AIndividual patient expanded access requests may be considered for patients ...
Location
Multiple Locations